REYON Pharmaceutical Co., Ltd. (KRX:102460)
9,740.00
-160.00 (-1.62%)
Oct 23, 2026, 3:30 PM KST
REYON Pharmaceutical Market Cap
REYON Pharmaceutical has a market cap or net worth of 178.64 billion as of October 23, 2026. It is the 23,142nd most valuable company in the world and the 887th biggest in South Korea. Its market cap has decreased by 11.70% in one year.
Market Cap
178.64B
Enterprise Value
388.46B
Revenue
143.37B
Global Rank
Country Rank
#887 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since June 10, 2010, REYON Pharmaceutical's market cap has increased from 164.55B to 178.64B, an increase of 8.56%. That is a compound annual growth rate of 0.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 178.64B | -9.65% |
| Dec 30, 2025 | 197.72B | -16.04% |
| Dec 30, 2024 | 235.50B | -22.37% |
| Dec 28, 2023 | 303.36B | -21.07% |
| Dec 29, 2022 | 384.35B | -39.10% |
| Dec 30, 2021 | 631.11B | 61.64% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Huons | 202.39B |
| Suheung | 201.90B |
| Whan In Pharm | 188.54B |
| Hyundai Pharmaceutical | 187.93B |
| Yungjin Pharm. | 180.33B |
| Samil Pharmaceutical Co.,Ltd | 175.88B |
| AptaBio Therapeutics | 175.30B |
| BNC KOREA | 175.09B |